Bringing the fundamentals into focus…
Bringing the fundamentals into focus…
IRD · against 338 other Healthcare companies of similar size
Ranked #333 of 339 · scores higher than 1% of peers
Bars: peers in each 10-point band of the growth score49 peers with a growth score of 0–9, including IRD · Click a bar to see the companies
Mainly because of its 3-year revenue growth and revenue growth, which are weaker than most Healthcare peers.
| Metric | IRD | Peer median | Better than | Position among peers | Weight |
|---|---|---|---|---|---|
| Revenue growthHigher is better · 352 reported | -36.1% | 3.0% | 8% | 33% | |
| Earnings per share growthHigher is better · 163 reported | Not reported | 3.6% | — | — | 33% |
| 3-year revenue growthHigher is better · 330 reported | -39.8% | 3.8% | 3% | 33% |
A metric that is not reported is left out of the score; the other weights are rescaled.
| Rank | Company | Market cap | Growth | Overall |
|---|---|---|---|---|
| 1 | 464M USD | 100 | 53 | |
| 2 | 1.8B HKD (≈$224M) | 99 | 59 | |
| 2 | 7.2B TWD (≈$224M) | 99 | 41 | |
| 2 | 433M USD | 99 | 81 | |
| 2 | 609M USD | 99 | 91 | |
| 330 | 3.5B HKD (≈$451M) | 2 | 51 | |
| 330 | 4.0B CNY (≈$563M) | 2 | 18 | |
| 330 | 366M CHF (≈$421M) | 2 | 23 | |
| 333 | 3.4B CNY (≈$482M) | 1 | 22 | |
| 333 | 327M USD | 1 | 11 | |
| 335 | 4.6B CNY (≈$645M) | 0 | 17 | |
| 335 | 389M USD | 0 | 33 | |
| 335 | 530M USD | 0 | 23 | |
| 335 | 454M AUD (≈$299M) | 0 | 7 |
Scores are sector-relative percentiles from the latest snapshot, always calculated against the whole sector: narrowing the comparison group changes who you compare with, not the scores. Missing metrics are left out and the remaining weights rescaled. How we score